Synthesis of 1,3,5-triazinethiones(ones) and their potential for practical application
Bulletin of the South Ural State University series "Chemistry" · 2026 · 18 (1) · 75-136
DOI: 10.14529/chem260109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of the South Ural State University series "Chemistry", 2026. Verfasst von A. Golovina und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The present review deals with various derivatives of 1,3,5-triazinones and 1,3,5-triazinethiones. The review provides comprehensive discussion of synthetic approaches to the synthesis of s triazinones(thiones) and their O-(S-)derivatives, as well as the potential for their practical application. Currently, 1,3,5-triazinones(thiones) and their derivatives are widely used in various fields: agriculture, industry, pharmaceutical production, organic synthesis, and production of highly porous covalent triazine frameworks with various properties. Due to the strong interest in these heterocyclic systems, driven by their high biological activity and widespread use of compounds with the 1,3,5-triazine framework, we have searched, analyzed, and systematized available literature sources from 1952 to 2025, including patent documents.
Zitieren
APA
Golovina, A., & Rybakova, A. (2026). Synthesis of 1,3,5-triazinethiones(ones) and their potential for practical application. Bulletin of the South Ural State University series "Chemistry", 18(1), 75-136. https://doi.org/10.14529/chem260109
Vancouver
Golovina A, Rybakova A. Synthesis of 1,3,5-triazinethiones(ones) and their potential for practical application. Bulletin of the South Ural State University series "Chemistry". 2026;18(1):75-136. doi:10.14529/chem260109
BibTeX
@article{Golovina2026,
author = {Golovina, A. and Rybakova, A.},
title = {Synthesis of 1,3,5-triazinethiones(ones) and their potential for practical application},
journal = {Bulletin of the South Ural State University series "Chemistry"},
year = {2026},
volume = {18},
number = {1},
pages = {75--136},
doi = {10.14529/chem260109}
}
EUVIMED